Beovu User Reviews & Ratings
Beovu has an average rating of 7.0 out of 10 from a total of 3 reviews on Drugs.com. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Macular Degeneration | 3 reviews for Macular Degeneration | 17 medications |
- RMO...
- Taken for 10 years or more
- March 16, 2023
For Macular Degeneration "Have taken Wet AMD injections since 2011. Avastin for 6 months, Eylea for 7 1/2 years. Beovu for 3 years and 3 months."
- jer...
- Taken for less than 1 month
- July 29, 2022
For Macular Degeneration "Stay away from Beovu - it blinded me in my left eye - use something else instead."
See also:
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Ozurdex
Ozurdex is an implant injected into the eye to treat swelling that may occur when there is a ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Byooviz
Byooviz injection is used to treat types of macular degeneration, macular edema and mCNV. Byooviz ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Frequently asked questions
- Does Beovu help with wet AMD?
- Does Medicare cover Beovu?
- What is brolucizumab used for and how does it work?
- How is brolucizumab administered?
Are you taking this medicine?
Your review helps others make informed decisions.More about Beovu (brolucizumab)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
For Macular Degeneration "Has been working much better than Eylea or Lucentis and so much better not to have to be injected every 30 days."